(198 days)
Not Found
No
The summary describes a physical implant device and its mechanical properties, with no mention of software, algorithms, or data processing that would indicate AI/ML.
Yes.
The device is indicated for spinal fusion procedures to treat degenerative disc disease, which addresses a medical condition and aims to restore function.
No
Explanation: The device is an intervertebral body fusion device intended for spinal fusion procedures, not for diagnosing medical conditions.
No
The device description clearly states that the Zavation Ti 3Z Interbody System implants are physical implants made from titanium powder, which are additively manufactured. This indicates a hardware device, not a software-only device.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description: The provided text describes a physical implant designed to be surgically placed in the lumbar spine for fusion procedures. It is a medical device used in vivo (within the body), not in vitro (outside the body).
- Intended Use: The intended use clearly states it's for spinal fusion procedures to treat degenerative disc disease. This is a surgical intervention, not a diagnostic test performed on a sample.
The device is a surgical implant, not a diagnostic tool.
N/A
Intended Use / Indications for Use
When used as a lumbar intervertebral body fusion device, the Zavation Ti 3Z Interbody System implants are indicated for spinal fusion procedures to be used with autogenous bone graft in skeletally mature patients are intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease (DDD) with up to Grade I spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The lumbar device is intended to be used in patients who have had six months of non-operative treatment.
For all the above indications the Zavation Ti 3Z Interbody implants are intended to be used with supplemental internal fixation appropriate for the implanted level, including Zavation Pedicle Screw System.
Product codes (comma separated list FDA assigned to the subject device)
MAX
Device Description
The Zavation Ti 3Z Interbody implants offer a variety of heights, widths and lengths. There are five main configurations: ALIF, LLIF, TLIF, T-PLIF, PLIF. The different configurations allow for multiple surgical technique options. The implants are additively manufactured from medical grade Titanium Ti64ELI powder by way of laser sintering.
The Zavation Ti 3Z Interbody implants are available in a range of sizes, as well as parallel and lordotic angled implants, to accommodate variations in patients' anatomy. The internal body of the implants have a porous structure while the external edges of the implants have a solid, roughened surface designed to engage with the vertebral body end plates. Both porous and solid aspects of each implant are printed simultaneously.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
lumbar spine, from L2 to S1
Indicated Patient Age Range
skeletally mature patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Mechanical test results demonstrated that the Zavation Ti 3Z Interbody System is substantially equivalent to the predicate devices. Testing was performed in accordance with:
- ASTM F2077, Test Methods for Intervertebral Body Fusion Devices
- Static Axial Compression
- Dynamic Axial Compression
- Static Compression Shear
- Dynamic Compression Shear
- Static Torsion
- Subsidence
- Expulsion
Process Validation test results demonstrate that the Zavation Ti 3Z Interbody System is free from any possible contaminants and the cleaning process is adequate for implants to be provided sterile.
- ASTM F 2847-10, Standard Practice for Reporting Assessment of Residues on Single Use Implants
- Gravimetric Analysis, ASTM F 2459-12
- Cytotoxicity, ISO 10993-5: 2009
- Total Organic Carbon
- Limulus Amebocyte Lysate (LAL) (Endotoxin)
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3080 Intervertebral body fusion device.
(a)
Identification. An intervertebral body fusion device is an implanted single or multiple component spinal device made from a variety of materials, including titanium and polymers. The device is inserted into the intervertebral body space of the cervical or lumbosacral spine, and is intended for intervertebral body fusion.(b)
Classification. (1) Class II (special controls) for intervertebral body fusion devices that contain bone grafting material. The special control is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intervertebral Body Fusion Device.” See § 888.1(e) for the availability of this guidance document.(2) Class III (premarket approval) for intervertebral body fusion devices that include any therapeutic biologic (e.g., bone morphogenic protein). Intervertebral body fusion devices that contain any therapeutic biologic require premarket approval.
(c)
Date premarket approval application (PMA) or notice of product development protocol (PDP) is required. Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left, there is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
Zavation Medical Products, LLC Katie Motley Design Engineer 220 Lakeland Parkway Flowood, Mississippi 39232
Re: K180076
Trade/Device Name: Ti 3Z Interbody System Regulation Number: 21 CFR 888.3080 Regulation Name: Intervertebral Body Fusion Device Regulatory Class: Class II Product Code: MAX Dated: June 26, 2018 Received: June 27, 2018
Dear Ms. Motley:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov
July 27, 2018
1
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Melissa Hall -S
For Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known)
Device Name Ti 3Z Interbody System
Indications for Use (Describe)
When used as a lumbar intervertebral body fusion device, the Zavation Ti 3Z Interbody System implants are indicated for spinal fusion procedures to be used with autogenous bone graft in skeletally mature patients are intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease (DDD) with up to Grade I spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The lumbar device is intended to be used in patients who have had six months of non-operative treatment.
For all the above indications the Zavation Ti 3Z Interbody implants are intended to be used with supplemental internal fixation appropriate for the implanted level, including Zavation Pedicle Screw System.
| Type of Use (Select one or both, as applicable) | |||
|---|---|---|---|
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below.
3
510K Summary
| Date: | January 9, 2018 |
|---|---|
| Submitter: | Zavation Medical Products, LLC |
| 220 Lakeland Pkwy | |
| Flowood, MS 39232 | |
| Phone: 601-919-1119 | |
| Fax: 800-447-1302 | |
| Contact person: | Katie Motley |
| Type of 510(k) submission: | Traditional |
| Trade name: | Ti 3Z Interbody System |
| Common name: | Intervertebral Body Fusion Device |
| Classification regulation: | 888.3080 (MAX) |
| Device classification: | Class II |
| Classification Panel: | Orthopedic |
| Product code: | MAX |
Device Description:
The Zavation Ti 3Z Interbody implants offer a variety of heights, widths and lengths. There are five main configurations: ALIF, LLIF, TLIF, T-PLIF, PLIF. The different configurations allow for multiple surgical technique options. The implants are additively manufactured from medical grade Titanium Ti64ELI powder by way of laser sintering.
The Zavation Ti 3Z Interbody implants are available in a range of sizes, as well as parallel and lordotic angled implants, to accommodate variations in patients' anatomy. The internal body of the implants have a porous structure while the external edges of the implants have a solid, roughened surface designed to engage with the vertebral body end plates. Both porous and solid aspects of each implant are printed simultaneously.
Purpose of 510K:
New Interbody Device.
Indications for Use:
When used as a lumbar intervertebral body fusion device, the Zavation Ti 3Z Interbody implants are indicated for spinal fusion procedures to be used with autogenous bone graft in skeletally
4
mature patients. The lumbar IBF implants are intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease (DDD) with up to Grade I spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The lumbar device is intended to be used in patients who have had six months of non-operative treatment.
For all the above indications the Zavation Ti 3Z Interbody implants are intended to be used with supplemental internal fixation appropriate for the implanted level, including Zavation Pedicle Screw System.
Materials:
The devices are manufactured from medical grade Titanium Ti64ELI (ASTM F3001-14).
Predicate Device:
Primary -Zavation IBF System, Zavation LLC (K112664) Additional - Stryker Spine Tritanium® PL Cage (K152304) Additional - K122097 Globus Medical Patriot® Spacers (Continental™ ALIF and TransContinental®)
Technological Characteristics:
The Zavation Ti 3Z Interbody System possesses similar technological characteristics as the predicates. These include: basic design (material, rectangular shape with bulleted nose, and graft windows for packing autogenous bone); sizes (similar heights, widths, lengths, and lordotic angles); and intended use (as described above).
Performance Data:
Mechanical test results demonstrated that the Zavation Ti 3Z Interbody System is substantially equivalent to the predicate devices. Testing was performed in accordance with:
- ASTM F2077, Test Methods for Intervertebral Body Fusion Devices ●
- Static Axial Compression O
- Dynamic Axial Compression O
- Static Compression Shear O
- Dynamic Compression Shear O
- O Static Torsion
- Subsidence O
- Expulsion O
Process Validation test results demonstrate that the Zavation Ti 3Z Interbody System is free from any possible contaminants and the cleaning process is adequate for implants to be provided sterile.
- ASTM F 2847-10, Standard Practice for Reporting Assessment of Residues on Single Use Implants
- O Gravimetric Analysis, ASTM F 2459-12
- o Cytotoxicity, ISO 10993-5: 2009
- o Total Organic Carbon
- o Limulus Amebocyte Lysate (LAL) (Endotoxin)
5
Basis for Substantial Equivalence:
The Zavation Ti 3Z Interbody devices are similar to the predicate systems with respect to technical characteristics, performance, and intended use. The information provided within this premarket notification supports substantial equivalence of the subject spacers to the predicate devices.